Amgen Information, Including Revenue, Investors, Funding, Competitors & Key Metrics

Amgen is a biotechnology company that develops and manufactures human therapeutics for various illnesses and diseases. The company is values-based and deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious diseases. They offer products for treating illness in the areas of oncology/hematology, cardiovascular, inflammation, bone health, nephrology, and neuroscience.

Company Highlights
Year Founded

1980

icon-altEmployees

36,276

Location (HQ)

USA

Since Last Funding

1 year 12 months

Monthly Website Visitors

539.6K

icon-altTotal Investment Amt

$29B

Last Funding Round

Post Ipo Debt

icon-altMoM Headcount Growth

0.46%

icon-altYoY Headcount Growth

14.96%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Health Care

Biotechnology Research

Manufacturing